View Post

FDA Warns NSAID Use After 20 Weeks of Pregnancy Could Lead to Complications

In its Drug Safety Communication, dated 10/15/2020, the Food and Drug Administration (FDA) announced that manufacturers of nonsteroidal anti-inflammatory drugs (NSAIDs) will be required to update their labeling to include warnings about potential fetal risk if women take the medications at about 20 weeks or later in their pregnancy. This is of special concern to dentistry since the use of …

View Post

FDA issues warning about dangerous “Benadryl Challenge” seen on social media.

Recently, a “Benadryl Challenge” posted on the social media application TikTok has prompted the U.S. Food and Drug Administration (FDA) to issue a Drug Safety Communication regarding the dangers of consuming larger than recommended doses of the OTC allergy medicine Benadryl®(diphenhydramine). In its Drug Safety Communication, the Agency stated that it was aware of news reports of teenagers presenting in …

View Post

New Asthma Indication for Triple-Ingredient Inhaler May Increase Orosystemic Complications

Recently, the Food and Drug Administration (FDA) approved the supplemental New Drug Application for Trelegy Ellipta® for the maintenance treatment of asthma in patients aged 18 years and older. This new indication is in addition to Trelegy Ellipta®’s previous indication for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. This new indication, and resulting increased market demand, …

View Post

Opioid Analgesics vs. Non-Opioid Analgesics For Post-Extraction Dental Pain 

A recent study, published in March 2020 in JAMA Network Open, sought to understand the differences in patient-reported outcomes between patients who used opioids and those who did not use opioids after dental procedures, in an effort to encourage the adoption of more conservative and appropriate prescribing practices in dentistry. The study was conducted in the 14 dental clinics of …